scholarly journals CORNEAL COLLAGEN CROSS LINKING (CXL) IN TREATMENT OF PSEUDOPHAKIC BULLOUS KERATOPATHY

1969 ◽  
Vol 32 (4) ◽  
Author(s):  
Muhammad Saim Khan ◽  
Imran Basit ◽  
Mazhar Ishaq ◽  
Tariq Shakoor ◽  
Amer Yaqub ◽  
...  
Ophthalmology ◽  
2013 ◽  
Vol 120 (12) ◽  
pp. 2413-2418 ◽  
Author(s):  
Ritu Arora ◽  
Aditi Manudhane ◽  
Ravindra Kumar Saran ◽  
Jawaharlal Goyal ◽  
Gaurav Goyal ◽  
...  

2013 ◽  
Vol 18 (2) ◽  
pp. 168-173 ◽  
Author(s):  
Simon A. Pot ◽  
Nicolin S. Gallhöfer ◽  
Ladina Walser-Reinhardt ◽  
Farhad Hafezi ◽  
Bernhard M. Spiess

2009 ◽  
Vol 25 (8) ◽  
pp. 687-687 ◽  
Author(s):  
Sally Hayes ◽  
Christina S Kamma-Lorger

2021 ◽  
Vol 8 (3) ◽  
pp. 186-193
Author(s):  
Katarzyna Przewłócka ◽  
Piotr Kanclerz

Corneal collagen cross-linking, a technique used in ophthalmology, involves the creation of new bonds between collagen fibers, thus leading to stabilization and corneal stiffening. The most common indication for corneal collagen cross-linking procedures is to prevent the progression of corneal ectasia,\ i.e., keratoconus, pellucid marginal degeneration, and ectasia after corneal refractive surgery. Clinical data also indicate that it is effective in the treatment of bacterial corneal infections and bullous keratopathy. Corneal collagen cross-linking was shown to inhibit the progression of corneal ectasia, and the treatment commonly leads to the improvement in visual acuity, decreases the maximum keratometry values, and improves the corneal topography image. In addition, it is possible to avoid or postpone the need for more complex and invasive surgery.


2016 ◽  
Vol 85 (3) ◽  
Author(s):  
Mirna Štabuc Šilih

Corneal collagen cross-linking increases the stability of the cornea through the use of the photosensitive material - riboflavin (vitamin B2) and ultraviolet A radiation. Progressive keratoconus is the most common indication and the frequency of these procedures is increasing worldwide. As cross-links in the cornea are a physiological principle of all connective tissue, additional indications were proposed. These include postrefractive surgery ectasia, bullous keratopathy, and, infectious keratitis.Infectious keratitis can lead to blindness without proper antimicrobial therapy. But even prompt initial management, with appropriate antimicrobial treatment, can be subjected to microorganism sensitivity and resistance.This article presents current data regarding the use of corneal collagen cross-linking in the treatment of corneal infections. This treatment modality may become important, but unanswered questions remain. Larger, prospective comparative studies should give the answers.


Sign in / Sign up

Export Citation Format

Share Document